查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1637300

狗疫苗市場 - 全球產業規模、佔有率、趨勢、機會和預測，按疫苗類型、疾病類型、免疫持續時間、給藥途徑、地區和競爭細分，2020-2030F

Dog Vaccines Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Vaccine Type, By Disease Type, By Duration of Immunity, By Route of Administration, By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024 年，全球狗疫苗市場估值為18.6 億美元，預計在預測期內將達到26.9 億美元，到2030 年複合年成長率為6.32%。全球狗疫苗市場正在經歷顯著成長關於動物健康的關注不斷加強。寵物主人越來越意識到為他們的狗提供預防性醫療保健的重要性，這推動了對預防各種傳染病的疫苗的需求。隨著獸醫護理標準的提高和寵物健康知識的增加，狗疫苗已成為負責任的寵物飼養的重要方面。更有效、更有針對性的疫苗的出現進一步促進了市場成長，因為寵物主人尋求透過疫苗接種計劃確保寵物的健康。

市場概況
預測期 2026-2030
2024 年市場規模 18.6億美元
2030 年市場規模 26.9億美元
2025-2030 年複合年成長率 6.32%
成長最快的細分市場 口服
最大的市場 北美洲

該市場的主要驅動力之一是全球寵物收養數量的不斷增加。隨著越來越多的人選擇歡迎狗進入家中，為保護寵物免受狂犬病、犬瘟熱、細小病毒和鉤端螺旋體病等疾病的常規疫苗接種的需求不斷增加。此外，疫苗技術的進步導致了更有效且副作用更少的疫苗的開發，從而鼓勵寵物主人更多地採用疫苗。隨著獸醫診所和動物保健服務變得更加容易取得並配備先進的診斷和治療技術，對疫苗的需求持續成長。

然而，狗疫苗市場存在必須解決的挑戰才能維持成長。某些疫苗的高昂成本以及某些地區疫苗的供應有限可能會阻礙許多寵物主人獲得預防性護理。此外，對疫苗相關副作用的擔憂以及寵物替代醫學的日益普及可能會影響市場擴張。儘管有這些挑戰，寵物保險的成長趨勢和鼓勵疫苗接種計畫的政府法規為進一步成長提供了機會。隨著寵物主人對寵物的健康投入更多，對狗疫苗的需求預計將繼續上升，因為需要採取預防措施來確保狗的壽命和健康。

主要市場促進因素

寵物擁有量不斷增加

疫苗技術的進步

獸醫醫療基礎設施的發展

主要市場挑戰

疫苗接種費用高

疫苗相關副作用

主要市場趨勢

個人化疫苗和客製化方法

組合疫苗日益受到關注

細分市場洞察

疫苗類型見解

疾病類型見解

區域洞察

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：客戶之聲

第 5 章：全球狗疫苗市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依疫苗類型（改良/減毒活疫苗、去活化（去活化）疫苗、其他）
    • 依疾病類型（犬瘟熱、犬傳染性呼吸道疾病症候群（CIRDC）、犬小病毒病/細小病毒病、犬鉤端螺旋體病、犬萊姆病、犬傳染性肝炎、犬狂犬病、其他）
    • 依免疫期限（1年、3年、其他）
    • 依給藥途徑（注射劑、鼻內、口服）
    • 按公司分類 (2024)
    • 按地區
  • 市場地圖

第 6 章：北美狗疫苗市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按疫苗類型
    • 依疾病類型
    • 按免疫持續時間
    • 依給藥途徑
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第 7 章：歐洲狗疫苗市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按疫苗類型
    • 依疾病類型
    • 按免疫持續時間
    • 依給藥途徑
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第 8 章：亞太地區狗疫苗市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按疫苗類型
    • 依疾病類型
    • 按免疫持續時間
    • 依給藥途徑
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲

第 9 章：南美狗疫苗市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按疫苗類型
    • 依疾病類型
    • 按免疫持續時間
    • 依給藥途徑
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲狗疫苗市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 按疫苗類型
    • 依疾病類型
    • 按免疫持續時間
    • 依給藥途徑
    • 按國家/地區
  • MEA：國家分析
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國

第 11 章：市場動態

  • 促進要素
  • 挑戰

第 12 章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新動態

第 13 章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第14章：競爭格局

  • Zoetis Inc.
  • Bioveta as
  • Hester Biosciences Limited
  • Boehringer Ingelheim International GmbH
  • Brilliant Bio Pharma Private Limited
  • Heska Corporation
  • Merck & Co., Inc.
  • Virbac SA
  • Zendal Group
  • Elanco Animal Health Incorporated

第 15 章：策略建議

第16章調查會社について,免責事項

簡介目錄
Product Code: 27122

Global Dog Vaccines Market was valued at USD 1.86 Billion in 2024 and is expected to reach USD 2.69 Billion in the forecast period with a CAGR of 6.32% through 2030. The global dog vaccines market is experiencing significant growth as pet ownership continues to rise and awareness about animal health intensifies. Pet owners are becoming increasingly conscious of the importance of preventative healthcare for their dogs, driving demand for vaccines that prevent a variety of infectious diseases. As veterinary care standards improve and pet health knowledge increases, dog vaccines have become a vital aspect of responsible pet ownership. The availability of more effective and targeted vaccines has further bolstered market growth, as pet owners seek to ensure the well-being of their pets through vaccination programs.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.86 Billion
Market Size 2030USD 2.69 Billion
CAGR 2025-20306.32%
Fastest Growing SegmentOral
Largest MarketNorth America

One of the key drivers of this market is the growing number of pet adoptions worldwide. With more people choosing to welcome dogs into their homes, the need for routine vaccinations to protect pets from diseases such as rabies, distemper, parvovirus, and leptospirosis is on the rise. In addition, advances in vaccine technology have led to the development of more effective vaccines with fewer side effects, thus encouraging greater adoption among pet owners. As veterinary clinics and animal healthcare services become more accessible and equipped with advanced diagnostic and treatment technologies, the demand for vaccines continues to rise.

However, there are challenges within the dog vaccines market that must be addressed to sustain growth. The high cost of certain vaccines and the limited availability of vaccines in some regions can hinder access to preventative care for many pet owners. Moreover, concerns regarding vaccine-related side effects and the growing popularity of alternative medicine for pets could impact market expansion. Despite these challenges, the growing trend of pet insurance and government regulations encouraging vaccination programs present opportunities for further growth. As pet owners invest more in their pets' health, the demand for dog vaccines is expected to continue rising, driven by the need for preventive measures to ensure the longevity and health of dogs.

Key Market Drivers

Rising Pet Ownership

The surge in pet ownership worldwide has significantly influenced the global dog vaccines market. As more households welcome dogs as companions, the demand for comprehensive healthcare, including vaccinations, has escalated. In the United States, for instance, approximately 86.9 million households owned a pet in 2023, accounting for 66% of households. Among these, 65.1 million households had at least one dog, highlighting the substantial canine population.

This increase in pet ownership has led to a higher demand for veterinary services, including vaccinations. Pet owners are more inclined to invest in their pets' health, recognizing the importance of preventive care to ensure their dogs lead healthy and fulfilling lives. The growing number of pet owners has also contributed to the expansion of the pet healthcare market. This expansion is driven by the increasing humanization of pets, where owners view their pets as family members, leading to higher spending on pet-related products and services, including vaccines. As pet ownership continues to rise, the demand for dog vaccines is expected to grow correspondingly, presenting opportunities for market expansion and innovation in veterinary care.

Advancements in Vaccine Technology

Advancements in vaccine technology have been a critical driver of growth in the global dog vaccines market. The development of more effective and safer vaccines has significantly improved the ability to prevent a wide range of infectious diseases in dogs. New technologies such as recombinant DNA technology, adjuvant improvements, and mRNA vaccines are making it possible to create vaccines that offer enhanced protection while reducing the risk of side effects. These innovations ensure that dogs are better protected against diseases like rabies, distemper, parvovirus, and leptospirosis, contributing to improved pet health worldwide.

The rise of combination vaccines is another important advancement. Combination vaccines, which provide protection against several diseases with a single injection, are becoming increasingly popular. These vaccines simplify the vaccination process for pet owners by reducing the number of vet visits and injections required, making it easier to ensure that dogs are fully vaccinated. The development of these combination vaccines also makes vaccination more cost-effective, which further encourages adoption among pet owners.

Recent advancements also include the development of vaccines with extended protection periods. This means fewer booster shots are required over the life of the dog, which improves convenience for both pet owners and veterinarians. Improved stability of vaccines, which allows for easier storage and longer shelf life, has also expanded the accessibility of vaccines, particularly in remote areas where veterinary services may be limited.

These technological strides in vaccine development have not only increased the safety and efficacy of vaccines but also fostered greater confidence in pet vaccination programs, leading to higher vaccination rates. As these innovations continue, the global dog vaccines market is expected to experience sustained growth, benefiting from more accessible, efficient, and effective vaccination solutions for pet owners.

Growth of Veterinary Healthcare Infrastructure

The growth of veterinary healthcare infrastructure is a key driver for the expansion of the global dog vaccines market. As pet ownership continues to rise globally, there is a corresponding increase in demand for veterinary services, including vaccinations. The accessibility and quality of veterinary care have significantly improved in recent years, leading to higher vaccination rates among pets. This growth in infrastructure is evident through the establishment of more veterinary clinics and animal hospitals, especially in urban areas, which cater to the growing pet population. As of recent reports, there has been a notable surge in the number of veterinary professionals and clinics offering a wider range of services, from routine check-ups to specialized treatments.

The increasing number of pet owners worldwide has been a driving force behind the expansion of veterinary healthcare facilities. For example, in countries such as the United States, over 90 million households now own pets, which has created a larger market for pet healthcare services. This surge in pet ownership has prompted veterinary clinics to expand their operations and offer more comprehensive healthcare solutions. At the same time, advancements in veterinary care, such as improved diagnostic tools and treatment options, have made it easier for clinics to provide effective care, including timely vaccinations for pets.

Government initiatives also play a crucial role in supporting the growth of veterinary healthcare infrastructure. Several countries have implemented programs to promote animal health and strengthen the veterinary workforce, including funding for veterinary clinics and training for veterinary professionals. This, in turn, ensures greater access to vaccines for pets and contributes to higher vaccination rates. As more pet owners seek professional care for their animals, the demand for dog vaccines continues to rise, further fueling the market's growth. Improved infrastructure and government support are creating a favorable environment for increased pet vaccination, thereby driving the expansion of the dog vaccines market.

Key Market Challenges

High Cost of Vaccination

One of the major challenges facing the global dog vaccines market is the high cost of vaccination, which can limit access to essential preventive healthcare for pets, particularly in lower-income regions. The price of vaccines varies depending on the type of vaccine, the brand, and the country in which they are administered. Vaccination costs are influenced by several factors, including the research and development expenses involved in creating new vaccines, regulatory fees, and distribution costs. For example, combination vaccines, which provide protection against multiple diseases in one dose, can be more expensive than single vaccines, further escalating the overall cost for pet owners.

In addition to the direct costs of vaccines, pet owners may incur additional charges for veterinary consultations and health assessments to determine which vaccines are needed for their dogs. This makes the vaccination process financially challenging for individuals, especially in regions where veterinary care is not subsidized or where pet healthcare is not covered by insurance. According to a report from the American Kennel Club, a basic vaccination package for a dog in the U.S. can cost anywhere from USD 75 to USD 150, depending on the vaccines included. More advanced vaccines or those for rare diseases may cost even more. These costs can be a significant burden for pet owners in developing countries or low-income households, potentially resulting in lower vaccination rates.

For reference, the U.S. Centers for Disease Control and Prevention (CDC) provides cost data on rabies vaccination for pets, noting that rabies shots alone can cost between USD 15 and USD 30. However, pet owners are often required to cover the additional costs of vet visits and consultations, which can push the total cost of vaccination higher. The high cost of dog vaccines can hinder market growth by limiting access to vaccines in economically disadvantaged regions.

Vaccine-Related Side Effects

Vaccine-related side effects remain a significant challenge in the global dog vaccines market, despite the general safety of vaccines. While most vaccines are well-tolerated, some dogs may experience mild to severe reactions, which can deter pet owners from vaccinating their dogs. Common mild side effects include fever, lethargy, swelling at the injection site, or temporary loss of appetite, which typically subside within a few days. However, more severe reactions, such as anaphylaxis, allergic reactions, or autoimmune disorders, although rare, pose a higher risk. These adverse effects can lead to concern among pet owners, who may then become hesitant about vaccinating their pets in the future. This reluctance to vaccinate is especially problematic in areas with low vaccine coverage, where it can lead to increased vulnerability to preventable diseases.

The fear of potential side effects often arises from the lack of understanding among pet owners about the nature of these reactions and the real risks involved. Misconceptions about the frequency and severity of side effects contribute to vaccine hesitancy, as many pet owners may not be aware that the benefits of vaccination far outweigh the risks. Additionally, some alternative treatments and non-traditional medicine practices that claim to boost pet health without vaccines are gaining popularity, further exacerbating concerns about vaccination. This shift away from conventional vaccination practices, especially among pet owners who are more focused on natural or holistic approaches, presents a challenge to the overall success of vaccination campaigns. Veterinary professionals play a crucial role in educating pet owners about the safety and importance of vaccinations to combat these concerns and ensure that dogs remain protected from preventable diseases.

Key Market Trends

Personalized Vaccines and Tailored Approaches

Personalized vaccines and tailored approaches are becoming a significant trend in the global dog vaccines market as pet owners and veterinary professionals seek more precise and effective healthcare solutions. This trend involves customizing vaccination plans based on a dog's specific characteristics, such as breed, age, health status, environmental factors, and genetic predispositions. Veterinarians are increasingly using this personalized approach to better understand how different dogs respond to vaccines, ensuring that the vaccines administered are the most suitable for the individual animal. For example, certain breeds or dogs with pre-existing health conditions may be more susceptible to specific diseases, while others may require a different vaccination schedule or a modified vaccine dosage to avoid side effects.

Tailored vaccination plans also consider the dog's lifestyle and environment, which can impact its risk of exposure to infectious diseases. Dogs that live in areas with higher incidences of certain diseases or those that are exposed to other animals may need targeted vaccines for specific pathogens, while dogs in low-risk environments may need fewer vaccinations. Genetic testing is increasingly being used to understand a dog's immune system and its ability to respond to certain vaccines. This trend is driven by growing knowledge about animal genetics and immune responses, as well as advances in veterinary medicine.

Personalized vaccines not only improve the effectiveness of immunization but also help mitigate potential risks associated with over-vaccination. By tailoring vaccines to the specific needs of each dog, this approach reduces unnecessary vaccine administration, which can lower the risk of adverse reactions. As pet owners become more aware of the benefits of personalized care and as veterinary technology advances, the demand for tailored vaccination plans is expected to grow, shaping the future of pet healthcare.

Growing Focus on Combination Vaccines

The growing focus on combination vaccines in the global dog vaccines market is driven by the increasing demand for convenience, cost-effectiveness, and efficient healthcare solutions for pets. Combination vaccines, which protect dogs against multiple diseases with a single injection, have become a preferred option for pet owners and veterinarians alike. These vaccines reduce the number of visits to veterinary clinics, making them particularly appealing to pet owners with busy schedules or those in areas with limited access to veterinary services. By consolidating multiple vaccines into one, pet owners can ensure their dogs are protected from a variety of diseases while minimizing the time and cost associated with administering individual vaccines.

Combination vaccines are also beneficial from a health perspective, as they help maintain a streamlined vaccination schedule. The reduced number of injections lowers the risk of vaccine-related side effects, which may be a concern for some pet owners. This trend is particularly important as veterinary practices aim to enhance both the safety and efficacy of vaccination programs. The ability to target a wide range of diseases, such as distemper, parvovirus, and hepatitis, in one vaccine has made these products an essential part of routine pet healthcare, particularly for younger dogs who need to receive multiple vaccinations early in life.

As vaccine manufacturers continue to innovate, the development of new and improved combination vaccines is expected to expand, offering protection against an even broader range of diseases. This growth aligns with the rising trend of preventive healthcare for pets, as owners become more focused on proactive measures to safeguard their pets' health. The increasing adoption of combination vaccines is reshaping the dog vaccines market, offering both practical and economic benefits for pet owners while maintaining high levels of protection against infectious diseases.

Segmental Insights

Vaccine Type Insights

Based on the Vaccine Type, Modified/ Attenuated Live emerged as the dominant segment in the Global Dog Vaccines Market in 2024. This is primarily due to their proven efficacy and widespread use. These vaccines contain live pathogens that have been weakened to the point where they cannot cause disease but still stimulate a strong immune response in the animal. This type of vaccine has been widely used in veterinary medicine for many years because it provides long-lasting immunity and can protect dogs against several infectious diseases with a single dose. Modified/Attenuated Live vaccines are particularly effective for diseases such as distemper, parvovirus, and rabies, where robust immunity is essential to prevent the spread of potentially fatal conditions.

Additionally, the cost-effectiveness of Modified/Attenuated Live vaccines makes them a popular choice among veterinarians and pet owners. They often require fewer doses compared to inactivated vaccines, reducing the overall cost of vaccination programs. The ease of administration and availability of combination vaccines, which combine protection against multiple diseases in one shot, also contribute to the widespread adoption of Modified/Attenuated Live vaccines. Their ability to elicit strong, lasting immune responses, combined with practical benefits, ensures that this vaccine type continues to dominate the global dog vaccines market.

Disease Type Insights

Based on the Disease Type, Canine Infectious Respiratory Disease Complex (CIRDC) emerged as the dominant segment in the Global Dog Vaccines Market in 2024. This is driven by the high prevalence and significant impact of respiratory diseases in dogs. CIRDC, commonly known as kennel cough, is a highly contagious disease complex that affects the upper respiratory tract of dogs. It is caused by a combination of viruses and bacteria, including Bordetella bronchiseptica, parainfluenza virus, and canine adenovirus. These diseases are particularly common in environments where dogs are in close contact with each other, such as kennels, shelters, and dog parks. The high incidence of CIRDC, combined with its rapid transmission, has led to increased demand for vaccines that prevent this disease complex. Vaccines for CIRDC are essential in safeguarding the health of dogs, especially those in high-risk environments. The availability of vaccines that protect against multiple pathogens in the CIRDC spectrum, such as combination vaccines, has further driven the market's growth.

Regional Insights

North America emerged as the dominant region in the Global Dog Vaccines Market in 2024. This is largely due to several key factors, including a high level of pet ownership, advanced veterinary healthcare infrastructure, and strong regulatory frameworks. The United States and Canada have some of the highest rates of pet ownership globally, with millions of households owning dogs as pets. This large pet population drives the demand for preventive healthcare, including vaccines, to ensure the well-being of pets and prevent the spread of infectious diseases. Moreover, North America benefits from well-established veterinary clinics and hospitals equipped with the latest technologies for administering vaccines and providing comprehensive care. The region's advanced healthcare infrastructure, along with a strong network of veterinary professionals, ensures that pets receive timely and effective vaccinations. Additionally, pet owners in North America are increasingly focused on the health and longevity of their pets, which contributes to the widespread adoption of vaccination programs.

The regulatory environment in North America also plays a crucial role in promoting vaccination, as governments in the region have strict vaccination guidelines for pets, particularly for diseases like rabies. These regulations, combined with high awareness of pet health, have solidified North America's position as the dominant region in the global dog vaccines market.

Key Market Players

  • Zoetis Inc.
  • Bioveta a.s
  • Hester Biosciences Limited
  • Boehringer Ingelheim International GmbH
  • Brilliant Bio Pharma Private Limited
  • Heska Corporation
  • Merck & Co., Inc.
  • Virbac S.A.
  • Zendal Group
  • Elanco Animal Health Incorporated

Report Scope:

In this report, the Global Dog Vaccines Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Dog Vaccines Market, By Vaccine Type:

  • Modified/ Attenuated Live
  • Inactivated (Killed)
  • Others

Dog Vaccines Market, By Disease Type:

  • Canine Distemper
  • Canine Infectious Respiratory Disease Complex (CIRDC)
  • Canine Parvovirosis/ Parvovirus Disease
  • Canine Leptospirosis
  • Canine Lyme Disease
  • Infectious Canine Hepatitis
  • Canine Rabies
  • Others

Dog Vaccines Market, By Duration of Immunity:

  • 1 Year
  • 3 Year
  • Others

Dog Vaccines Market, By Route of Administration:

  • Injectables
  • Intranasal
  • Oral

Dog Vaccines Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Dog Vaccines Market.

Available Customizations:

Global Dog Vaccines Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Voice of Customer

5. Global Dog Vaccines Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Vaccine Type (Modified/ Attenuated Live, Inactivated (Killed), Others)
    • 5.2.2. By Disease Type (Canine Distemper, Canine Infectious Respiratory Disease Complex (CIRDC), Canine Parvovirosis/ Parvovirus Disease, Canine Leptospirosis, Canine Lyme Disease, Infectious Canine Hepatitis, Canine Rabies, Others)
    • 5.2.3. By Duration of Immunity (1 Year, 3 Year, Others)
    • 5.2.4. By Route of Administration (Injectables, Intranasal, Oral)
    • 5.2.5. By Company (2024)
    • 5.2.6. By Region
  • 5.3. Market Map

6. North America Dog Vaccines Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Vaccine Type
    • 6.2.2. By Disease Type
    • 6.2.3. By Duration of Immunity
    • 6.2.4. By Route of Administration
    • 6.2.5. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Dog Vaccines Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Vaccine Type
        • 6.3.1.2.2. By Disease Type
        • 6.3.1.2.3. By Duration of Immunity
        • 6.3.1.2.4. By Route of Administration
    • 6.3.2. Mexico Dog Vaccines Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Vaccine Type
        • 6.3.2.2.2. By Disease Type
        • 6.3.2.2.3. By Duration of Immunity
        • 6.3.2.2.4. By Route of Administration
    • 6.3.3. Canada Dog Vaccines Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Vaccine Type
        • 6.3.3.2.2. By Disease Type
        • 6.3.3.2.3. By Duration of Immunity
        • 6.3.3.2.4. By Route of Administration

7. Europe Dog Vaccines Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Vaccine Type
    • 7.2.2. By Disease Type
    • 7.2.3. By Duration of Immunity
    • 7.2.4. By Route of Administration
    • 7.2.5. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Dog Vaccines Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Vaccine Type
        • 7.3.1.2.2. By Disease Type
        • 7.3.1.2.3. By Duration of Immunity
        • 7.3.1.2.4. By Route of Administration
    • 7.3.2. Germany Dog Vaccines Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Vaccine Type
        • 7.3.2.2.2. By Disease Type
        • 7.3.2.2.3. By Duration of Immunity
        • 7.3.2.2.4. By Route of Administration
    • 7.3.3. United Kingdom Dog Vaccines Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Vaccine Type
        • 7.3.3.2.2. By Disease Type
        • 7.3.3.2.3. By Duration of Immunity
        • 7.3.3.2.4. By Route of Administration
    • 7.3.4. Italy Dog Vaccines Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Vaccine Type
        • 7.3.4.2.2. By Disease Type
        • 7.3.4.2.3. By Duration of Immunity
        • 7.3.4.2.4. By Route of Administration
    • 7.3.5. Spain Dog Vaccines Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Vaccine Type
        • 7.3.5.2.2. By Disease Type
        • 7.3.5.2.3. By Duration of Immunity
        • 7.3.5.2.4. By Route of Administration

8. Asia-Pacific Dog Vaccines Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Vaccine Type
    • 8.2.2. By Disease Type
    • 8.2.3. By Duration of Immunity
    • 8.2.4. By Route of Administration
    • 8.2.5. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Dog Vaccines Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Vaccine Type
        • 8.3.1.2.2. By Disease Type
        • 8.3.1.2.3. By Duration of Immunity
        • 8.3.1.2.4. By Route of Administration
    • 8.3.2. India Dog Vaccines Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Vaccine Type
        • 8.3.2.2.2. By Disease Type
        • 8.3.2.2.3. By Duration of Immunity
        • 8.3.2.2.4. By Route of Administration
    • 8.3.3. South Korea Dog Vaccines Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Vaccine Type
        • 8.3.3.2.2. By Disease Type
        • 8.3.3.2.3. By Duration of Immunity
        • 8.3.3.2.4. By Route of Administration
    • 8.3.4. Japan Dog Vaccines Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Vaccine Type
        • 8.3.4.2.2. By Disease Type
        • 8.3.4.2.3. By Duration of Immunity
        • 8.3.4.2.4. By Route of Administration
    • 8.3.5. Australia Dog Vaccines Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Vaccine Type
        • 8.3.5.2.2. By Disease Type
        • 8.3.5.2.3. By Duration of Immunity
        • 8.3.5.2.4. By Route of Administration

9. South America Dog Vaccines Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Vaccine Type
    • 9.2.2. By Disease Type
    • 9.2.3. By Duration of Immunity
    • 9.2.4. By Route of Administration
    • 9.2.5. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Dog Vaccines Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Vaccine Type
        • 9.3.1.2.2. By Disease Type
        • 9.3.1.2.3. By Duration of Immunity
        • 9.3.1.2.4. By Route of Administration
    • 9.3.2. Argentina Dog Vaccines Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Vaccine Type
        • 9.3.2.2.2. By Disease Type
        • 9.3.2.2.3. By Duration of Immunity
        • 9.3.2.2.4. By Route of Administration
    • 9.3.3. Colombia Dog Vaccines Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Vaccine Type
        • 9.3.3.2.2. By Disease Type
        • 9.3.3.2.3. By Duration of Immunity
        • 9.3.3.2.4. By Route of Administration

10. Middle East and Africa Dog Vaccines Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Vaccine Type
    • 10.2.2. By Disease Type
    • 10.2.3. By Duration of Immunity
    • 10.2.4. By Route of Administration
    • 10.2.5. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Dog Vaccines Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Vaccine Type
        • 10.3.1.2.2. By Disease Type
        • 10.3.1.2.3. By Duration of Immunity
        • 10.3.1.2.4. By Route of Administration
    • 10.3.2. Saudi Arabia Dog Vaccines Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Vaccine Type
        • 10.3.2.2.2. By Disease Type
        • 10.3.2.2.3. By Duration of Immunity
        • 10.3.2.2.4. By Route of Administration
    • 10.3.3. UAE Dog Vaccines Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Vaccine Type
        • 10.3.3.2.2. By Disease Type
        • 10.3.3.2.3. By Duration of Immunity
        • 10.3.3.2.4. By Route of Administration

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Porters Five Forces Analysis

  • 13.1. Competition in the Industry
  • 13.2. Potential of New Entrants
  • 13.3. Power of Suppliers
  • 13.4. Power of Customers
  • 13.5. Threat of Substitute Products

14. Competitive Landscape

  • 14.1. Zoetis Inc.
    • 14.1.1. Business Overview
    • 14.1.2. Company Snapshot
    • 14.1.3. Products & Services
    • 14.1.4. Financials (As Reported)
    • 14.1.5. Recent Developments
    • 14.1.6. Key Personnel Details
    • 14.1.7. SWOT Analysis
  • 14.2. Bioveta a.s
  • 14.3. Hester Biosciences Limited
  • 14.4. Boehringer Ingelheim International GmbH
  • 14.5. Brilliant Bio Pharma Private Limited
  • 14.6. Heska Corporation
  • 14.7. Merck & Co., Inc.
  • 14.8. Virbac S.A.
  • 14.9. Zendal Group
  • 14.10. Elanco Animal Health Incorporated

15. Strategic Recommendations

16. About Us & Disclaimer